Panagora Asset Management’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Panagora Asset Management’s Portfolio NVET Stock Details NVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-31,741	Closed	-$105K	–	2395
2016 Q1	$105K	Sell	31,741 -1,932	-6%	-$6.3K	﹤0.01%	1852
2015 Q4	$115K	Buy	33,673 +26,715	+384%	+$105K	﹤0.01%	1761
2015 Q3	$25K	Buy	+6,958	New	+$31.7K	﹤0.01%	2113

Other funds holding NVET

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

LLC

Latimer Light Capital New York $432M AUM 25.5% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Panagora Asset Management's NVET Position: Q2 2016 in Review

Panagora Asset Management sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q2 2016, closing a stake of 31,741 shares — an estimated $105K sold.

Panagora Asset Management first reported a position in NVET in Q3 2015 and held it in 3 quarters. The position peaked at $115K in Q4 2015. 15 funds tracked by Wall St. Rank hold NVET as of Q2 2016.

Panagora Asset Management reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q2 2016 after selling out during the quarter.
Panagora Asset Management sold 31,741 Nexvet Biopharma plc Ordinary Shares shares in Q2 2016, an estimated $105K.
Panagora Asset Management first reported a position in Nexvet Biopharma plc Ordinary Shares in Q3 2015 and held it in 3 quarters.
Panagora Asset Management's Nexvet Biopharma plc Ordinary Shares position peaked at $115K in Q4 2015.
15 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q2 2016.

Based on Panagora Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.